Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLEEVEC for Soft tissue cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where GLEEVEC was used for Soft tissue cancer.

Most Reported Side Effects for GLEEVEC

Side Effect Reports % Deaths Hosp.
Death 72 27.1% 72 3
Nausea 26 9.8% 3 10
Diarrhoea 24 9.0% 2 9
Fatigue 23 8.7% 1 8
Vomiting 23 8.7% 3 11
Fall 20 7.5% 1 12
Muscle spasms 18 6.8% 1 8
Asthenia 15 5.6% 1 10
Malaise 15 5.6% 2 8
Rash 14 5.3% 0 3
Malignant neoplasm progression 12 4.5% 4 8
Swelling 12 4.5% 1 7
Myalgia 11 4.1% 0 3
Pain 11 4.1% 0 6
Cerebrovascular accident 10 3.8% 2 4

Other Indications for GLEEVEC

Chronic myeloid leukaemia (94) Gastrointestinal stromal tumour (28) Gastric cancer (9) Neoplasm malignant (9) Soft tissue neoplasm (7) Soft tissue sarcoma (6) Acute lymphocytic leukaemia (5)

Other Drugs Used for Soft tissue cancer

VOTRIENT (13)

Related Pages

GLEEVEC Full Profile All Soft tissue cancer Drugs GLEEVEC Demographics GLEEVEC Timeline